No. This acquisiton is "all scrip", i.e IHL will be printing new shares to grant APIRx to "pay" for the acquisition.
Capital raised from the bonus options will not be used for this.
I think the most likely thing is that the bonus options are to soften to dilution blow to exiting holders when these new shares get issued (around 180m units)
- Forums
- ASX - By Stock
- IHL
- Ann: Incannex to Acquire APIRx Pharmaceuticals
Ann: Incannex to Acquire APIRx Pharmaceuticals, page-25
-
-
- There are more pages in this discussion • 436 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)